Cyril Ronco
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Discovery and Optimization of a Trichloroacetamidine Scaffold as a Novel Antibacterial against Multidrug-Resistant Staphylococcus aureus.
Journal: ACS medicinal chemistry letters
Published: October 29, 2025
Therapeutic strategies targeting ocular vasculopathies: Current advances and emerging challenges.
Journal: Drug discovery today
Published: July 24, 2025
Discovery of pyrimidine-based small activators of insulin degrading enzyme.
Journal: European journal of medicinal chemistry
Published: June 10, 2025
Optimised arylbiamidine derivative as potent in vivo antimelanoma agent: Drug-to-target approach reveals nanomolar GSK3β inhibition.
Journal: Bioorganic chemistry
Published: January 10, 2025
A Potent Solution for Tumor Growth and Angiogenesis Suppression via an ELR+CXCL-CXCR1/2 Pathway Inhibitor.
Journal: ACS medicinal chemistry letters
Published: January 31, 2024
Topical treatment for age-related macular degeneration: Where are we now?
Journal: Medecine sciences : M/S
Published: December 18, 2023
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 13, 2023
Design, Synthesis and Biological Evaluation of Novel Anticancer Amidinourea Analogues via Unexpected 1,3,5-Triazin-2-one Ring Opening.
Journal: ChemMedChem
Published: September 13, 2023
Recent Advances in Age-Related Macular Degeneration Therapies.
Journal: Molecules (Basel, Switzerland)
Published: July 08, 2022
In vivo monitoring of the therapeutic efficacy of a CXCR1/2 inhibitor with 18F-FDG PET/CT imaging in experimental head and neck carcinoma: A feasibility study.
Journal: Biochemistry and biophysics reports
Published: June 27, 2021
Last Updated: 09/26/2026